Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Gilead to present 28 abstracts on HIV treatment, prevention and emerging antiviral research at IDWeek 2026


GSK’s Jemperli wins FDA approval as first immunotherapy for MSI-H/dMMR locally advanced rectal cancer


Bristol Myers Squibb to present late-breaking iza-bren, pumitamig and Opdivo plus Yervoy data across solid tumours at ESMO 2026


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Just in Time Release of CAR T Cell Therapies

Presented by Irving Ford, Head of CAR T QC Laboratories at Celgene and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
11th November 2019


A Versatile Solution for Host Cell Proteins (HCPs) and Aggregates Removal for mAbs Purification

Presented by Catherine Allioux & Caine Leong, Ph.D.
08th June 2017


Effect of Cell Culture Process Change from Fed-batch to Continuous on Productivity and Product Quality

Presented by Ru Zang, Associate Director at Mersana Therapeutics and John Bonham Carter, Product Line Lead, Cell Culture and Clarification Business at Repligen
25th February 2019


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia